318 related articles for article (PubMed ID: 12710012)
1. VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
De La Fuente-Fernández R; Furtado S; Guttman M; Furukawa Y; Lee CS; Calne DB; Ruth TJ; Stoessl AJ
Synapse; 2003 Jul; 49(1):20-8. PubMed ID: 12710012
[TBL] [Abstract][Full Text] [Related]
2. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
Kilbourn MR; Kuszpit K; Sherman P
Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
[TBL] [Abstract][Full Text] [Related]
3. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
Lee CS; Samii A; Sossi V; Ruth TJ; Schulzer M; Holden JE; Wudel J; Pal PK; de la Fuente-Fernandez R; Calne DB; Stoessl AJ
Ann Neurol; 2000 Apr; 47(4):493-503. PubMed ID: 10762161
[TBL] [Abstract][Full Text] [Related]
4. Age and severity of nigrostriatal damage at onset of Parkinson's disease.
De La Fuente-Fernández R; Lim AS; Sossi V; Adam MJ; Ruth TJ; Calne DB; Stoessl AJ; Lee CS
Synapse; 2003 Feb; 47(2):152-8. PubMed ID: 12454953
[TBL] [Abstract][Full Text] [Related]
5. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
Kilbourn MR; Sherman PS; Kuszpit K
Synapse; 2002 Mar; 43(3):188-94. PubMed ID: 11793424
[TBL] [Abstract][Full Text] [Related]
6. In vivo measurement of the vesicular monoamine transporter in schizophrenia.
Taylor SF; Koeppe RA; Tandon R; Zubieta JK; Frey KA
Neuropsychopharmacology; 2000 Dec; 23(6):667-75. PubMed ID: 11063922
[TBL] [Abstract][Full Text] [Related]
7. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
Teng L; Crooks PA; Dwoskin LP
J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
[TBL] [Abstract][Full Text] [Related]
8. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
Frey KA; Koeppe RA; Kilbourn MR; Vander Borght TM; Albin RL; Gilman S; Kuhl DE
Ann Neurol; 1996 Dec; 40(6):873-84. PubMed ID: 9007092
[TBL] [Abstract][Full Text] [Related]
9. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR
J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
[TBL] [Abstract][Full Text] [Related]
10. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome.
Meyer P; Bohnen NI; Minoshima S; Koeppe RA; Wernette K; Kilbourn MR; Kuhl DE; Frey KA; Albin RL
Neurology; 1999 Jul; 53(2):371-4. PubMed ID: 10430428
[TBL] [Abstract][Full Text] [Related]
11. Increased ventral striatal monoaminergic innervation in Tourette syndrome.
Albin RL; Koeppe RA; Bohnen NI; Nichols TE; Meyer P; Wernette K; Minoshima S; Kilbourn MR; Frey KA
Neurology; 2003 Aug; 61(3):310-5. PubMed ID: 12913189
[TBL] [Abstract][Full Text] [Related]
12. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration.
Tong J; Wilson AA; Boileau I; Houle S; Kish SJ
Synapse; 2008 Nov; 62(11):873-6. PubMed ID: 18720517
[TBL] [Abstract][Full Text] [Related]
13. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
Boileau I; Rusjan P; Houle S; Wilkins D; Tong J; Selby P; Guttman M; Saint-Cyr JA; Wilson AA; Kish SJ
J Neurosci; 2008 Sep; 28(39):9850-6. PubMed ID: 18815269
[TBL] [Abstract][Full Text] [Related]
14. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
Suzuki M; Desmond TJ; Albin RL; Frey KA
Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
[TBL] [Abstract][Full Text] [Related]
15. Long-term reproducibility of in vivo measures of specific binding of radioligands in rat brain.
Kilbourn MR
Nucl Med Biol; 2004 Jul; 31(5):591-5. PubMed ID: 15219277
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors.
Rinne JO; Iivanainen M; Metsähonkala L; Vainionpää L; Pääkkönen L; Någren K; Helenius H
J Neural Transm (Vienna); 2004 Jan; 111(1):59-67. PubMed ID: 14714216
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
18. Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.
Hogan KA; Staal RG; Sonsalla PK
J Neurochem; 2000 May; 74(5):2217-20. PubMed ID: 10800969
[TBL] [Abstract][Full Text] [Related]
19. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
Adams JR; van Netten H; Schulzer M; Mak E; Mckenzie J; Strongosky A; Sossi V; Ruth TJ; Lee CS; Farrer M; Gasser T; Uitti RJ; Calne DB; Wszolek ZK; Stoessl AJ
Brain; 2005 Dec; 128(Pt 12):2777-85. PubMed ID: 16081470
[TBL] [Abstract][Full Text] [Related]
20. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
